Amphastar Pharmaceuticals (AMPH) EBT Margin (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) reported EBT Margin of 20.96% for Q2 2026, down 1.59 percentage points from 22.55% a year earlier but up 15.09 percentage points from the prior quarter.
Amphastar Pharmaceuticals (AMPH) EBT Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Amphastar Pharmaceuticals' EBT Margin came in at 13.98%, down 8.42 percentage points year-over-year; for FY2025, it was 17.17%, down 8.75 percentage points from FY2024.
- EBT Margin has a five-year change of +15.85 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at 25.93% in FY2024 (-0.67 pp), 26.59% in FY2023 (+3.34 pp), 23.26% in FY2022 (+4.04 pp) and 19.22% in FY2021 (+17.89 pp).
- Five-year quarterly EBT Margin spans a low of 5.87% in Q1 2026 and a high of 35.25% in Q3 2023.
- Year over year, EBT Margin has now declined in each of the last six quarters, with an average year-over-year change of -7.30 percentage points over the last eight quarters.
- The high point for year-over-year EBT Margin in five years was Q4 2021 (a gain of 29.50 percentage points); the low point was Q3 2022 (a drop of 14.74 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 5.87% (Q1 2026), 17.43% (Q4 2025) and 11.21% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Amphastar Pharmaceuticals | 1.16 Bn | 23.86 Mn | 93.47 Mn | 20.96% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.96% |
| Mar 31, 2026 | 5.87% |
| Dec 31, 2025 | 17.43% |
| Sep 30, 2025 | 11.21% |
| Jun 30, 2025 | 22.55% |
| Mar 31, 2025 | 18.10% |
| Dec 31, 2024 | 23.57% |
| Sep 30, 2024 | 24.94% |
| Jun 30, 2024 | 27.55% |
| Mar 31, 2024 | 27.86% |
| Dec 31, 2023 | 23.21% |
| Sep 30, 2023 | 35.25% |
| Jun 30, 2023 | 22.52% |
| Mar 31, 2023 | 23.97% |
| Dec 31, 2022 | 30.56% |
| Sep 30, 2022 | 18.81% |
| Jun 30, 2022 | 18.75% |
| Mar 31, 2022 | 24.12% |
| Dec 31, 2021 | 22.47% |
| Sep 30, 2021 | 33.55% |
Amphastar Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=AMPH&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "AMPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=AMPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();